Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhibitors of MEK/PI3K, JAK/MEK, JAK/PI3K/mTOR and MEK/PI3K/mTOR biological pathways and methods for improving lymphatic uptake, bioavailability, and solubility of therapeutic compounds

Inhibitors of MEK/PI3K, JAK/MEK, JAK/PI3K/mTOR and MEK/PI3K/mTOR biological pathways and methods for improving lymphatic uptake, bioavailability, and solubility of therapeutic compounds

US Patent 11311624 · Granted Apr 26, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tissue phasic classification mapping system and method2024
Stimulated circuits and fault testing methods2023
Multifunctional inhibitors of MEK/PI3K and mTOR/MEK/PI3K biological pathways and2021
Multifunctional inhibitors of MEK/PI3K and mTOR/MEK/PI3K biological pathways and2021
Techniques of deformation analysis for quantification of vascular enlargement2021
Systems and methods for topographical characterization of medical image data2020
Imaging agents and methods of use thereof2018
Error analysis and correction of MRI ADC measurements for gradient nonlinearity2017
Tissue phasic classification mapping system and method2017
Dual MEK/PI3K inhibitors and therapeutic methods using the same2017
Dual MEK/PI3K inhibitors and therapeutic methods using the same2017
Systems and methods for imaging changes in tissue2016